<?xml version="1.0"?>
<Articles JournalTitle="International Journal of Hematology-Oncology and Stem Cell Research">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>International Journal of Hematology-Oncology and Stem Cell Research</JournalTitle>
      <Issn>2008-2207</Issn>
      <Volume>2</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2005</Year>
        <Month>09</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">&#x3B2;-Globin Gene Cluster Haplotypes in Iranian Patients with &#x3B2;-Thalassemia</title>
    <FirstPage>30</FirstPage>
    <LastPage>34</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Z</FirstName>
        <LastName>Rahimi</LastName>
        <affiliation locale="en_US">Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran. AND Biochemistry Department, Medical School, Kermanshah University of Medical Sciences, Kermanshah, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>A</FirstName>
        <LastName>Merat</LastName>
        <affiliation locale="en_US">Biochemistry Department, Medical School, Shiraz University of Medical Sciences, Shiraz, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>M</FirstName>
        <LastName>Akhzari</LastName>
        <affiliation locale="en_US">Biochemistry Department, Medical School, Shiraz University of Medical Sciences, Shiraz, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>M</FirstName>
        <LastName>Haghshenass</LastName>
        <affiliation locale="en_US">Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Nagel</FirstName>
        <LastName>Ronald L</LastName>
        <affiliation locale="en_US">Department of Medicine, Division of Hematology; Department of Physiology and Biophysics, Albert Einstein College of Medicine, Bronx, NY, USA</affiliation>
      </Author>
      <Author>
        <FirstName>Gerard</FirstName>
        <LastName>Nathalie</LastName>
        <affiliation locale="en_US">NSERM U763, H&#xF4;pital Robert Debr&#xE8;, Paris, France</affiliation>
      </Author>
      <Author>
        <FirstName>Krish-namoorthy</FirstName>
        <LastName>Rajagopal</LastName>
        <affiliation locale="en_US">NSERM U763, H&#xF4;pital Robert Debr&#xE8;, Paris, France</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>01</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Introduction: &#x3B2;-globin gene cluster haplotypes are useful in diagnosis of particular molecular defects in &#x3B2;-thalassemia, prenatal diagnosis of &#x3B2;-thalassemia, and elucidating population affinities. 
Methods: &#x3B2;-globin gene cluster haplotypes were studied in 150 &#x3B2;-thalassemia minor and 52 healthy in-dividuals from the Fars province of Iran. DNA was extracted from leukocytes of whole blood by phe-nol-chloroform. Haplotype was determined by PCR-RFLP technique. }
Results: There were 26 out of 150 with homozygous haplotypes. Haplotype I was found as the most prevalent haplotype among both patients and normal individuals. Out of 26 patients bearing homozy-gous haplotypes, 12 (46.2%) had typical haplotype I and 3 (11.5%) had atypical haplotype I. The prevalence of haplotype I in normal control subjects was around 43% (45 out of 104 &#x3B2;A chromo-somes). The second prevalent haplotype was haplotypes V (15.4%) and III (15.4%) for homozygous patients and controls, respectively. The most frequent mutation in patients was IVS II.1 (G&#x2192;A) that was not linked to a single haplotype. IVS I.110 (G&#x2192;A) mutation was linked to haplotype I. Mutation in codon 30 (G&#x2192;A) was associated with haplotype V. 
Conclusion: Being Haplotype I the most prevalent haplotype in &#x3B2;-thal and &#x3B2;A chromosomes, implies that &#x3B2;-thalassemia mutations might have arisen in the chromosomal background common in the popula-tion, rather than due to selection pressure or gene flow (migration). Patients with haplotype IX had the highest HbF levels compared to other haplotypes.</abstract>
    <web_url>https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/198</web_url>
    <pdf_url>https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/download/198/191</pdf_url>
  </Article>
</Articles>
